Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.07 USD | -2.08% | -6.11% | -10.28% |
05-28 | Outlook Therapeutics Granted EU Marketing Authorization for Lytenava to Treat Wet AMD | MT |
05-21 | CoStar Group has room for expansion |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.28% | 169M | |
+43.36% | 58.06B | |
-5.31% | 40.53B | |
+37.52% | 38.99B | |
+14.75% | 26.7B | |
-12.56% | 26.56B | |
-22.45% | 18.98B | |
+0.04% | 12.17B | |
+25.12% | 12B | |
+26.04% | 11.92B |
- Stock Market
- Equities
- OTLK Stock
- News Outlook Therapeutics, Inc.
- Insider Buy: Outlook Therapeutics